Generative artificial intelligence, key new product launches, and the evolution of the go-to-market model are among key trends to watch in the year ahead.The Inflation Reduction Act (IRA), mergers and acquisitions, obesity-control drugs, and artificial intelligence (AI) dominated the pharma industry’s headlines in 2023. And although they will continue to be a part of industry […]
